United States · FDA National Drug Code directory
DILANTIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58151-110_872f23a8-e6a3-4038-922d-0c26fc81d8b3
- Product NDC
- 58151-110
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Extended Phenytoin Sodium
- Labeler
- Viatris Specialty LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241206
- Source listing expiry
- 20261231
Source-listed ingredients
- PHENYTOIN SODIUM — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (58151-110-01) · 58151-110-01
- 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (58151-110-10) · 58151-110-10
- 100 BLISTER PACK in 1 CARTON (58151-110-88) / 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (58151-110-32) · 58151-110-88
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →